<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03474978</url>
  </required_header>
  <id_info>
    <org_study_id>REB17-2371</org_study_id>
    <nct_id>NCT03474978</nct_id>
  </id_info>
  <brief_title>Peripherally Inserted Central Catheter Insertion Site and Complication Rate in Neonates</brief_title>
  <official_title>Peripherally Inserted Central Venous Catheter Insertion Site and Complication Rates in Neonates</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Calgary</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Calgary</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study examines whether there is an association between the PICC insertion site and the
      complications necessitating PICC removal in neonates admitted to neonatal intensive care
      unit.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2018</start_date>
  <completion_date type="Anticipated">April 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary outcome is the presence of any complication which necessitates PICC removal</measure>
    <time_frame>Through study completion, within 4 weeks</time_frame>
    <description>Line infiltration will be defined as extravasation of fluid into soft tissue around the region of the catheter tip. Line occlusion will be defined as inability to infuse fluid, resulting in removal of line. Phlebitis will be defined as presence of a linear red streak developing along the superficial veins from the catheter insertion site. Line associated thrombosis will be defined as ultrasound proven evidence of an occlusive thrombus in an anatomic location in proximity to the site of PICC.CLABSI will be defined according to Center for Disease Control definitions 26, that is, (1) confirmed primary bloodstream infection with (2) one of following clinical signs of infection (fever, hypothermia, apnea, or bradycardia) and (3) presence of central catheter at the time of or within 48 hours before the onset of the infection. Major life-threatening complications will include pleural effusion, pericardial effusion and cardiac tamponade, retroperitoneal extravasation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary outcome will be time to complication post insertion</measure>
    <time_frame>Through study completion, within 4 weeks</time_frame>
    <description>This will be defined as the interval between PICC line insertion and first detection of complication post insertion, expressed in days.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">320</enrollment>
  <condition>Catheterization, Peripheral</condition>
  <arm_group>
    <arm_group_label>Upper Extremity Insertion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Peripherally Inserted Central Venous Cather (PICC) inserted in upper extremity</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lower Extremity Insertion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Peripherally Inserted Central Venous Cather (PICC) inserted in lower extremity</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Peripherally Inserted Central Venous Cather (PICC)</intervention_name>
    <description>Location of the PICC insertion will be randomized and compared</description>
    <arm_group_label>Upper Extremity Insertion</arm_group_label>
    <arm_group_label>Lower Extremity Insertion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Neonates of all gestational ages admitted to Foothills Medical Centre and Alberta
             Children's Hospital Neonatal Intensive Care Unit (NICU)

          2. Peripherally inserted central venous catheter (PICC) line insertion planned as part of
             NICU care

          3. Venous access available in both upper(above umbilicus) and lower body

        Exclusion Criteria:

          1. Local infection at potential site of insertion

          2. Hemangioma, lymphangioma or malformations in the region of insertion

          3. Major chromosomal anomalies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>4 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amuchou Soraisham, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Calgary</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amuchou Soraisham, MD</last_name>
    <phone>403-944-8101</phone>
    <email>amuchou.soraisham@ahs.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Foothills Medical Centre</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N2T9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amuchou Soraisham, MD, DM, FRCPC</last_name>
      <phone>403-944-8101</phone>
      <email>amuchou.soraisham@ahs.ca</email>
    </contact>
    <contact_backup>
      <last_name>Harish Amin, MBBS, FRCPC</last_name>
      <phone>403-955-7513</phone>
      <email>harish.amin@ahs.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Amuchou Soraisham, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sumesh Thomas, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Harish Amin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kim Pearson, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Norma Oliver, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2018</study_first_submitted>
  <study_first_submitted_qc>March 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 23, 2018</study_first_posted>
  <last_update_submitted>May 1, 2018</last_update_submitted>
  <last_update_submitted_qc>May 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Calgary</investigator_affiliation>
    <investigator_full_name>Amuchou Soraisham</investigator_full_name>
    <investigator_title>Neonatologist</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

